Loading clinical trials...
Loading clinical trials...
A Phase II Study of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
Conditions
Interventions
Cisplatin
Hyperthermic Intraperitoneal Chemotherapy
+1 more
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
September 1, 2016
Primary Completion Date
April 11, 2023
Completion Date
April 11, 2023
Last Updated
September 19, 2024
NCT06340711
NCT04389632
NCT06078709
NCT05969860
NCT04895709
NCT04704661
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions